Role of stromal fibroblasts in cancer: promoting or impeding?
- PMID: 19440007
- DOI: 10.1159/000218708
Role of stromal fibroblasts in cancer: promoting or impeding?
Abstract
The basement membrane, immune cells, capillaries, fibroblasts and extracellular matrix (ECM) constitute the tumour stroma, commonly referred to as the 'reactive stroma'. The fibroblasts from the initial stages of a tumour, as the main constituents of the reactive stroma, present a different phenotype from the normal fibroblasts and play a crucial role in tumour progression. This review presents the differences between normal and tumour stromal fibroblasts and analyzes the molecular mechanisms (which involve growth factors, ECM components, matrix metalloproteinases, integrins and cell adhesion molecules) in the complex interactions between stromal fibroblasts and tumour cells. To date, several examples of heterotypic interactions between tumour stromal fibroblasts and tumour cells have supported the hypothesis that the tumour stroma promotes the growth of the tumour mass, as well as invasion and metastasis. However, it remains possible that the stroma acts essentially as a local modulator to impede tumorigenesis at an early stage and that the desmoplastic response is a host defence reaction designed to confine the developing tumour. The latter hypothesis has largely been neglected. The review aims to give a broader view on the role of stromal fibroblasts in tumour growth, invasion and metastasis.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.J Thorac Oncol. 2011 Jan;6(1):209-17. doi: 10.1097/JTO.0b013e3181f8a1bd. J Thorac Oncol. 2011. PMID: 21107292 Review.
-
Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion.Pathol Res Pract. 1996 Jul;192(7):712-7. doi: 10.1016/S0344-0338(96)80093-8. Pathol Res Pract. 1996. PMID: 8880872 Review.
-
Stromal myofibroblasts are drivers of invasive cancer growth.Int J Cancer. 2008 Nov 15;123(10):2229-38. doi: 10.1002/ijc.23925. Int J Cancer. 2008. PMID: 18777559 Review.
-
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?Lung Cancer. 2004 Aug;45 Suppl 2:S163-75. doi: 10.1016/j.lungcan.2004.07.977. Lung Cancer. 2004. PMID: 15552797 Review.
-
The role of proteoglycans in the reactive stroma on tumor growth and progression.Histol Histopathol. 2015 Jan;30(1):33-41. doi: 10.14670/HH-30.33. Epub 2014 Jun 16. Histol Histopathol. 2015. PMID: 24931397 Review.
Cited by
-
Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma.Front Med (Lausanne). 2015 Oct 5;2:72. doi: 10.3389/fmed.2015.00072. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26501061 Free PMC article. Review.
-
Characterization of tumor progression in engineered tissue using infrared spectroscopic imaging.Analyst. 2010 Jul;135(7):1569-78. doi: 10.1039/c0an00112k. Epub 2010 May 25. Analyst. 2010. PMID: 20498913 Free PMC article.
-
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.Iran J Cancer Prev. 2014 Winter;7(1):17-21. Iran J Cancer Prev. 2014. PMID: 25250143 Free PMC article.
-
Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.Oncotarget. 2015 Oct 6;6(30):29929-46. doi: 10.18632/oncotarget.4966. Oncotarget. 2015. PMID: 26338966 Free PMC article.
-
Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii.Front Public Health. 2021 Mar 1;9:650022. doi: 10.3389/fpubh.2021.650022. eCollection 2021. Front Public Health. 2021. PMID: 33732680 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources